1997
DOI: 10.1037/0022-006x.65.3.355
|View full text |Cite
|
Sign up to set email alerts
|

Evidence that therapy works in clincally representative conditions.

Abstract: This article reports a secondary analysis of past therapy outcome meta-analysis. Fifteen meta-analysis provided effect sizes from 56 studies in previous reviews that met 1 of 3 increasingly stringent levels of criteria for clinical representativeness. The effect sizes were synthesized and compared with results from the original meta-analyses. Effect sizes from more clinically representative studies are the same size at all 3 criteria levels as in past meta-analyses. Almost no studies exist that meet the most s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
125
0
5

Year Published

1999
1999
2014
2014

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 167 publications
(132 citation statements)
references
References 101 publications
(86 reference statements)
1
125
0
5
Order By: Relevance
“…Despite some evidence from clinical trials suggesting that efficacy corresponds to effectiveness (e.g., Shadish, Matt, Navarro, & Phillips, 2000;Shadish et al, 1997), there are few outcome data from clinical settings to suggest that treatments in these settings (i.e., treatment as usual; TAU) attain the benefits observed in clinical trials.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Despite some evidence from clinical trials suggesting that efficacy corresponds to effectiveness (e.g., Shadish, Matt, Navarro, & Phillips, 2000;Shadish et al, 1997), there are few outcome data from clinical settings to suggest that treatments in these settings (i.e., treatment as usual; TAU) attain the benefits observed in clinical trials.…”
mentioning
confidence: 99%
“…One factor that Weersing and Weisz (2002) did not explicitly pursue as a potential methodological issue in conducting benchmarking studies was the reactivity and specificity of outcome measures, which have repeatedly been shown to significantly affect the effect size estimates of treatment outcomes (Lambert & Bergin, 1994;Lambert, Hatch, Kingston, & Edwards, 1986;Robinson, Berman, & Neimeyer, 1990;Shadish et al, 1993Shadish et al, , 1997Shadish et al, , 2000Shapiro & Shapiro, 1982;Smith, Glass, & Miller, 1980). Reactivity is generally concerned with the sensitivity of the measure produced by the rater of the outcome-notably, an observer (either the treating clinician or an independent rater) or the client.…”
mentioning
confidence: 99%
“…[1][2][3][4][5] Treatment effectiveness refers to broader, 'real-world' outcomes assessment that is applicable beyond the narrow limitations of the clinical trial environment. This applies, for example, to the selection of inclusion and exclusion criteria in clinical trials, particularly with regard to partner relationship and other psychosocial variables.…”
Section: Introductionmentioning
confidence: 99%
“…En este sentido, sería recomendable contar con más estudios similares en otros centros y contextos diferentes. A pesar de esto, conviene recordar que los centros universitarios han sido considerados centros representativos de la práctica clínica en el ámbito asistencial privado por otros autores (Borkovec, 2004;Shadish et al, 1997Shadish et al, , 2000.…”
Section: Discusión Y Conclusionesunclassified